Literature DB >> 33534976

Management of Antithrombotic Therapy after Acute Coronary Syndromes.

Fatima Rodriguez1, Robert A Harrington1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33534976      PMCID： PMC9275395          DOI： 10.1056/NEJMra1607714

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   176.079


× No keyword cloud information.
  61 in total

Review 1.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

2.  Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.

Authors:  Satoshi Yasuda; Koichi Kaikita; Masaharu Akao; Junya Ako; Tetsuya Matoba; Masato Nakamura; Katsumi Miyauchi; Nobuhisa Hagiwara; Kazuo Kimura; Atsushi Hirayama; Kunihiko Matsui; Hisao Ogawa
Journal:  N Engl J Med       Date:  2019-09-02       Impact factor: 91.245

Review 3.  Genetic and non-genetic factors affecting the response to clopidogrel therapy.

Authors:  Marta Karaźniewicz-Łada; Dorota Danielak; Franciszek Główka
Journal:  Expert Opin Pharmacother       Date:  2012-03-07       Impact factor: 3.889

4.  Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.

Authors:  Thomas O Bergmeijer; Paul W A Janssen; Mathijs van Oevelen; Dymphie van Rooijen; Thea C Godschalk; Johannes C Kelder; Vera H M Deneer; Victor L Serebruany; Jurriën M Ten Berg
Journal:  Cardiology       Date:  2017-07-12       Impact factor: 1.869

Review 5.  Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Authors:  Francesco Costa; David van Klaveren; Stefan James; Dik Heg; Lorenz Räber; Fausto Feres; Thomas Pilgrim; Myeong-Ki Hong; Hyo-Soo Kim; Antonio Colombo; Philippe Gabriel Steg; Thomas Zanchin; Tullio Palmerini; Lars Wallentin; Deepak L Bhatt; Gregg W Stone; Stephan Windecker; Ewout W Steyerberg; Marco Valgimigli
Journal:  Lancet       Date:  2017-03-11       Impact factor: 79.321

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 7.  Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Authors:  Davide Capodanno; Kurt Huber; Roxana Mehran; Gregory Y H Lip; David P Faxon; Christopher B Granger; Pascal Vranckx; Renato D Lopes; Gilles Montalescot; Christopher P Cannon; Jurien Ten Berg; Bernard J Gersh; Deepak L Bhatt; Dominick J Angiolillo
Journal:  J Am Coll Cardiol       Date:  2019-07-09       Impact factor: 24.094

8.  Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation.

Authors:  Tullio Palmerini; Antonio G Bruno; Martine Gilard; Marie-Claude Morice; Marco Valgimigli; Gilles Montalescot; Jean-Philippe Collet; Diego Della Riva; Maria Letizia Bacchi-Reggiani; Philippe Gabriel Steg; Abdourahmane Diallo; Eric Vicaut; Gerard Helft; Masato Nakamura; Philippe Généreux; Torsten P Vahl; Gregg W Stone
Journal:  Circ Cardiovasc Interv       Date:  2019-03       Impact factor: 6.546

9.  Long-term use of ticagrelor in patients with prior myocardial infarction.

Authors:  Marc P Bonaca; Deepak L Bhatt; Marc Cohen; Philippe Gabriel Steg; Robert F Storey; Eva C Jensen; Giulia Magnani; Sameer Bansilal; M Polly Fish; Kyungah Im; Olof Bengtsson; Ton Oude Ophuis; Andrzej Budaj; Pierre Theroux; Mikhail Ruda; Christian Hamm; Shinya Goto; Jindrich Spinar; José Carlos Nicolau; Robert G Kiss; Sabina A Murphy; Stephen D Wiviott; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

10.  Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.

Authors:  John H Alexander; Daniel Wojdyla; Amit N Vora; Laine Thomas; Christopher B Granger; Shaun G Goodman; Ronald Aronson; Stephan Windecker; Roxana Mehran; Renato D Lopes
Journal:  Circulation       Date:  2020-03-29       Impact factor: 29.690
View more
  8 in total

1.  Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial.

Authors:  Diego Araiza-Garaygordobil; Rodrigo Gopar-Nieto; Daniel Sierra-Lara Martínez; Nallely Belderrain-Morales; Vianney Sarabia-Chao; Diana Laura Alfaro-Ponce; Heriberto Ontiveros-Mercado; Salvador Mendoza-García; Alfredo Altamirano-Castillo; Pablo Martinez-Amezcua; Alejandro Cabello-López; Jose Luis Briseño-De la Cruz; Maximiliano Ruiz-Beltrán; Marco Antonio Martínez-Ríos; Yigal Piña-Reyna; Hector Gonzalez-Pacheco; Alexandra Arias-Mendoza
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-07-29

Review 2.  Optimal Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Focused Review on High Bleeding Risk.

Authors:  Yunosuke Matsuura; Kohei Moribayashi; Koichi Kaikita
Journal:  J Atheroscler Thromb       Date:  2022-08-06       Impact factor: 4.394

3.  Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial.

Authors:  Ki Hong Choi; Yong Hwan Park; Young Bin Song; Taek Kyu Park; Joo Myung Lee; Jeong Hoon Yang; Jin-Ho Choi; Seung-Hyuk Choi; Ju-Hyeon Oh; Woo Jung Chun; Woo Jin Jang; Eul-Soon Im; Jin-Ok Jeong; Byung Ryul Cho; Seok Kyu Oh; Kyeong Ho Yun; Deok-Kyu Cho; Jong-Young Lee; Young-Youp Koh; Jang-Whan Bae; Jae Woong Choi; Wang Soo Lee; Hyuck Jun Yoon; Seung Uk Lee; Jang Hyun Cho; Woong Gil Choi; Seung-Woon Rha; Hyeon-Cheol Gwon; Joo-Yong Hahn
Journal:  JAMA Cardiol       Date:  2022-09-28       Impact factor: 30.154

4.  Dioscin elevates lncRNA MANTIS in therapeutic angiogenesis for heart diseases.

Authors:  Chuiyu Kong; Dayin Lyu; Chang He; Rui Li; Qiulun Lu
Journal:  Aging Cell       Date:  2021-06-03       Impact factor: 9.304

5.  Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis.

Authors:  Ioannis T Farmakis; Stefanos Zafeiropoulos; Ioannis Doundoulakis; Areti Pagiantza; Efstratios Karagiannidis; Dimitrios V Moysidis; Nikolaos Stalikas; George Kassimis; Lampros K Michalis; Haralambos Karvounis; George Giannakoulas
Journal:  Open Heart       Date:  2022-04

6.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

Authors:  Jeffrey S Berger; Lucy Z Kornblith; Michelle N Gong; Harmony R Reynolds; Mary Cushman; Yu Cheng; Bryan J McVerry; Keri S Kim; Renato D Lopes; Bassel Atassi; Scott Berry; Grant Bochicchio; Murillo de Oliveira Antunes; Michael E Farkouh; Yonatan Greenstein; Erinn M Hade; Kristin Hudock; Robert Hyzy; Pooja Khatri; Andrei Kindzelski; Bridget-Anne Kirwan; Lisa Baumann Kreuziger; Patrick R Lawler; Eric Leifer; Jose Lopez-Sendon Moreno; Jose Lopez-Sendon; James F Luther; Lilia Nigro Maia; John Quigley; Robert Sherwin; Lana Wahid; Jennifer Wilson; Judith S Hochman; Matthew D Neal
Journal:  JAMA       Date:  2022-01-18       Impact factor: 157.335

Review 7.  Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy.

Authors:  Qixiao Guan; Hongjing Dou
Journal:  Front Physiol       Date:  2021-11-30       Impact factor: 4.566

8.  Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy.

Authors:  Sheng-Wei Huang; Po-Wei Chen; Wen-Han Feng; I-Chang Hsieh; Ming-Yun Ho; Chung-Wei Cheng; Hung-I Yeh; Ching-Pei Chen; Wei-Chun Huang; Ching-Chang Fang; Hui-Wen Lin; Sheng-Hsiang Lin; Chin-Feng Tsai; Chun-Hung Su; Yi-Heng Li
Journal:  Front Cardiovasc Med       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.